V026-9106 Screening compound: 1-[1-(4-chlorobenzoyl)-4-(2,5-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine

V026-9106 Screening compound: 1-[1-(4-chlorobenzoyl)-4-(2,5-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine
V026-9106 Screening compound: 1-[1-(4-chlorobenzoyl)-4-(2,5-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-9106
1-[1-(4-chlorobenzoyl)-4-(2,5-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-9106

Molecular Formula

C31H34ClN3O4 (C31 H34 ClN3 O4)

Compound Name

1-[1-(4-chlorobenzoyl)-4-(2,5-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine

IUPAC name

1-[1-(4-chlorobenzoyl)-4-(25-dimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methylphenyl)piperazine

SMILES

Cc(cccc1)c1N(CC1)CCN1C(C(CN(C1)C(c(cc2)ccc2Cl)=O)C1c(cc(cc1)OC)c1OC)=O

InChI

InChI=1S/C31H34ClN3O4/c1-21-6-4-5-7-28(21)33-14-16-34(17-15-33)31(37)27-20-35(30(36)22-8-10-23(32)11-9-22)19-26(27)25-18-24(38-2)12-13-29(25)39-3/h4-13,18,26-27H,14-17,19-20H2,1-3H3

InChI Key

FUOCTYPETGFCMB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14262398

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.08

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.329

Distribution Coefficient, logD

5.329

Water Solubility, LogSw

-5.90

Polar Surface Area

51.630

Acid Dissociation Constant (pKa)

21.09

Base Dissociation Constant (pKb)

4.83

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.50

V026-9106 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V026-9106 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-9106?
Check Price and Availability of V026-9106, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-9106 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-9106
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-9106
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-9106 available by request